Showing posts with label health. Show all posts
Showing posts with label health. Show all posts

Saturday, September 22, 2012

HPTN 052

HPTN 052 is the name of a clinical trial which examined the extent to which antiretroviral therapy (ART) can, when taken by people who have HIV, decrease their infectivity and thereby reduce the chance that they will pass HIV on to their sexual partners. The results of the study were so compelling, that the study's Data and Safety Monitoring Board (DSMB) asked the research team to share the results with all study participants and offer ART to the control group before the study ended. The study continues to determine if the results - that ART can reduce the transmission of HIV by 96% - have durability. The trial was organized by the HIV Prevention Trials Network (HPTN).

nucleic acid amplification test

Synriam

Indian pharmaceutical firm Ranbaxy has launched the drug Synriam, which it claims will prove a more efficient and simpler treatment for malaria.

Thursday, June 28, 2012

The science behind Total Sanitation Campaign

  • Minister Jairam Ramesh has initiated the Nirmal Bharat Abhiyan (NBA) or Total Sanitation Campaign, which would attempt to banish open defecation within a decade. 
  • Dr. Humphrey has suggested an culprit, which is the major cause behind stunted growth and underweight in children in their pre-school years.
  • This is referred to as tropical enteropathy. This is a condition which affects the intestines (hence entero-) by killing or disabling the villi and microvilli covering the surface of the small intestine, and helping the absorption of the digested food into the blood and lymphatic systems.
  • It also leads to inflammation and mal-absorption. The benefits of whatever the child eats are not being transferred and utilised in the system for growth and development.
  • And the cause of tropical enteropathy is infection by the bacteria found in faeces. Children (and adults) living in conditions of poor sanitation are affected in great measure by such faecal bacterial infection leading to enteropathy.
  • As evidence, Humphrey points out to several studies done mostly in the 1960s in Asia, Africa and Central America, which showed a large number of adults and children living in poor sanitary conditions suffering from tropical enteropathy.
  • That the environmental sanitation is responsible is also suggested by studies on American soldiers in Vietnam and Peace Corps volunteers in Pakistan, who contracted tropical enteropathy while there, but recovered soon after returning to the U.S. Thus, NBA has a scientific basis behind it.
Many non-governmental organizations have been at the same mission with varying degrees of success.
  • Sulabh Shauchalaya, (www.sulabhinternational.org) initiated in many cities by Mr. Bindeshwar Pathak, has been a boon to hundreds of thousands of people.
  • The Gramalaya group in Tiruchi has now gone beyond towns and helps Anganwadis in some parts of Tamil Nadu. Another notable effort is that of the renowned nutrition scientist Dr. Mahtab Bamji and the gynaecologist Dr. Devyani Dangoria, both of Hyderabad, have been working with several villages in the Narsapur area in Medak district.They work with the women there on matters of maternal and child health, nutrition, kitchen gardens for vegetables and greens, education of children and adults, and sanitation.They have helped the villagers make safe and usable latrines by stacking up 4-foot wide cement rings, and digging pits underneath. A bit of the cost is shared by the owner and the rest by the Nirmal Gram Abhiyan programme of CAPART.They can make over 600 of them within the much talked about Rs. 35 lakhs. Thus NBA has several models to think about and improve upon.
What have been some of the issues in constructing such toilets? Bamji and Sunita list several. Water will of course be the major one; recall hand-washing alone can solve half the problem of infection.
Second, the type of soil is an issue. Use of night soil as manure apparently depends on the type of soil into which the waste goes. There is thus a practical problem here that needs to be addressed as NBA helps build toilets across India. Third is a matter of what and how the users would like the toilet. It appears that several of them feel “claustrophobic” in an enclosed space. NBA might want to take the help of land/building designers on this issue.
Could they announce a national region-wise competition for designing rural toilets suited to the local conditions of soil, water, population density, micro-environment and other relevant features? As Sunita Narain has said, out-of-the-box thinking is needed here.
Ultimately, it is mindset that needs to change. Habits have to change. If Sikkim can do it (it is the first Nirmal Rajya — 100 per cent open defecation-free), the rest of us can do it too!
Let us move from being burdened by the ‘dreamy desert sands of dead habit’ and move to an India where every child and adult is assured of good sanitation.
The body, mind and well-being of future Indians are at stake without it. The accomplished actress Miss Vidya Balan, whom Minister Ramesh has recruited to help in this noble cause, has her role cut out.

Saturday, March 24, 2012

NRHM to be National Health Mission soon

  • The government proposes to convert the National Rural Health Mission (NRHM) into a National Health Mission to provide health care to the urban poor also, in the course of the 12th Plan.
  • Universal access to free generic essential medicines in public health institutions in a phased and time-bound manner will be ensured

Saturday, March 3, 2012

Health to be allotted 2.5 p.c. of GDP by end of Plan

  • A high-level meeting at the Prime Minister's Office decided on Wednesday to increase the total government expenditure on the health sector to 2.5 per cent of the GDP by the end of the coming 12th Plan period, from the current level of around 1.4 per cent of the GDP.

Saturday, February 25, 2012

India taken off polio endemic list by WHO

  • India, which has been polio-free for over a year now, was taken off the list of polio endemic countries by the World Health Organisation.
  • There were only four countries in the WHO endemic list, including Pakistan, Nigeria and Afghanistan.
  • After being removed from the list, India will have to remain polio free for the next two years to achieve the polio-free status with concerted efforts and an emergency preparedness and response plan

Monday, January 23, 2012

Silocosis

http://www.nlm.nih.gov/medlineplus/ency/article/000134.htm

Saturday, January 21, 2012

Drug-resistant TB cases notification mandatory in Maharashtra

  • Even as the Centre refused to acknowledge the emergence of totally drug resistant (TDR) TB cases, the Maharashtra government has decided to introduce mandatory notification of all multi drug resistant (MDR) and extensively drug resistant (XDR) tuberculosis cases. Non-compliance of this notification will attract punishment. The Maharashtra government will also adopt these cases and offer them free treatment.
  • All public and private sector laboratories will have to report any such suspected drug resistant cases, re-test them from a Revised National Tuberculosis Control Programme (RNTCP) accredited laboratory and treat all such confirmed drug resistant TB cases as per the RNTCP guidelines.
  • A statement issued by the Central team that visited Mumbai following reporting of 12 TDR TB cases — three of whom have since died — said that the cases has been “erroneously” labelled as TDR-TB and cases reported by Hinduja Hospital fall only within the category of Extensively Drug Resistant TB (XDR TB) based on standard WHO definitions.
  • Diagnosis of XDR TB must be based on microbiological confirmation from the accredited national reference laboratories namely National Institute of Research in TB in Chennai, National TB Institute in Bangalore and LRS Institute of TB and Respiratory Diseases in New Delhi.

Centre plans audits to keep a tab on proper use of NRHM funds

  • In the wake of the National Rural Health Mission (NRHM) scam that surfaced in Uttar Pradesh, the Centre is planning to conduct regular audits across the country to check whether the NRHM funds were properly utilised.
  • This is of utmost importance as NRHM has been extended for another five years during the 12 five year plan. A National Urban Health Mission is also being planned.
  • Pointing out that the audits would be easy to conduct, the health Ministry had a list of all hospitals and healthcare facilities run by the State governments. “Every year, centre allocates Rs. 15,000 crore to the State governments for upgrading healthcare infrastructure. Teams of officials will visit these facilities to see if the infrastructure had actually been provided
  • NRHM was launched in 2005 with a mission to provide accessible, equitable and affordable healthcare services to people. 
  • While 1.4 lakh personnel were added to the health system, infrastructure was strengthened by taking up the construction or renovation of 594 district hospitals, 2,721 community health centres, 5,459 primary health centres and 31,001 sub-centres in the country

Saturday, January 14, 2012

One Year of Polio Free India

  • India today has touched a milestone of being polio free for one whole year. The lone case of polio in 2011 was detected in a two year old girl in Panchla block of Howrah, West Bengal, with the onset of paralysis on 13th January 2011.

New vaccine for monkeys raises hopes in fight against AIDS

  • Scientists have developed a new vaccine that partially protects monkeys from an infection much similar to HIV, a breakthrough which they say could be a new weapon in the battle against AIDS.
  • Researchers at the University of Utah School of Medicine found that rhesus monkeys which received the new vaccine were 80 to 83 per cent less likely to get infected with the Simian immunodeficiency virus (SIV), a virus which is closely related to HIV, when exposed to it.
  • The experimental vaccine was engineered to trigger the monkeys' immune systems to fight the virus. Researchers often study the effects of an SIV vaccine in monkeys as a way to understand how to develop an HIV vaccine in humans.
  • This study demonstrates that the immune system can be prepared to respond to, and partially control, viral infection that mimics HIV-1 transmission in humans
  • At the start of the research, published in the journal Nature, 40 monkeys were injected with either the experimental vaccine or the placebo vaccine, and then given a booster shot at six months.
  • The monkeys were then exposed to SIV six times through intra-rectal administration of the virus six months later.
  • After the virus was given the first time, about 75 per cent of monkeys in the placebo group became infected, whereas only 12 to 25 per cent of those given the vaccine developed infections. After the third exposure, about half the animals that received the experimental vaccine were infected and by the sixth time, almost all the animals were infected.

The HUNGaMA (Hunger and Malnutrition) Survey Report- 2011

  • The HUNGaMA (Hunger and Malnutrition) Survey conducted across 112 rural districts of India in 2011 provides reliable estimates of child nutrition covering nearly 20% of Indian children.
  •  Of the 112 districts surveyed, 100 were selected from the bottom of a child development district index developed for UNICEF India in 2009, referred to as the 100 Focus Districts in this report.  These 100 districts are located in 6 states.
  • The HUNGaMA Survey shows that positive change for child nutrition in India is happening, including in the 100 Focus Districts. However rates of child malnutrition are still unacceptably high particularly in these Focus Districts where over 40 per cent of children are underweight and almost 60 per cent are stunted, meaning their height is much lower than the median height-for-age of the reference population.
  • The 100 Focus Districts are located across Bihar, Jharkhand, Madhya Pradesh, Orissa, Rajasthan and Uttar Pradesh – states which perform the worst on child nutrition.
  • The survey notes that the prevalence of malnutrition is significantly higher among children from low-income families. It found that children from Muslim or SC/ST households generally had worse nutrition indicators.
  • Birth weight is an important risk-factor for child malnutrition. The prevalence of underweight in children born with a weight below 2.5 kg is 50 per cent, while that among children born with a weight above 2.5 kg is 34 per cent.
  • The survey further found that awareness among mothers about nutrition is low — "92 per cent mothers had never heard the word malnutrition."
  • Highlighting the negligence shown towards girl children even in their early childhood, the report says the nutrition advantage girls have over boys in the first months of life seems to be reversed over time as they grow older.
  • The last such data released in 2004 — from a district level health survey — had measured malnutrition only in terms of weight, and had concluded that 53 per cent children in these districts were underweight.
  • Among the worst districts as per the new data are Malkangiri in Orissa with 57.75 per cent and Aurangabad in Bihar with 49.47 per cent children underweight. Shrawasti in Uttar Pradesh with 72.31 per cent, Rae Bareli with 70.40 per cent, Koraput in Orissa with 68.86 per cent and Dumka in Jharkhand with 63.65 per cent have the highest number of stunted children.

What is vaccine-derived polio?

  • Oral polio vaccine (OPV) contains a weakened version of poliovirus, activating an immune response in the body. A vaccinated person transmits the weakened virus to others, who also develop antibodies to polio, ultimately stopping transmission of poliovirus in a community.
  • In very rare instances, the virus in the vaccine can mutate into a form that can paralyse - this is what is known as a vaccine-derived poliovirus or VDPV.
  • If this virus regains the ability to circulate, it is called a circulating vaccine-derived poliovirus (cVDPV). As with naturally occurring poliovirus, the only protection against cVDPV is full vaccination.
  • The spread of a cVDPV shows that too many children remain under-immunized. A fully-immunized population will be protected from all strains of poliovirus, whether wild or vaccine-derived.
  • Over the past 10 years, more than 10 billion doses of OPV have been administered to more than 2.5 billion children. As a result more than 3.5 million polio cases were prevented. During that time, 18 outbreaks of cVDPVs have occurred in 16 countries, resulting in 510 VDPV cases.

Tuesday, January 10, 2012

New vaccine for monkeys raises hopes in fight against AIDS




  • Scientists have developed a new vaccine that partially protects monkeys from an infection much similar to HIV, a breakthrough which they say could be a new weapon in the battle against AIDS.
  • Researchers at the University of Utah School of Medicine found that rhesus monkeys which received the new vaccine were 80 to 83 per cent less likely to get infected with the Simian immunodeficiency virus (SIV), a virus which is closely related to HIV, when exposed to it.
  • The experimental vaccine was engineered to trigger the monkeys’ immune systems to fight the virus. Researchers often study the effects of an SIV vaccine in monkeys as a way to understand how to develop an HIV vaccine in humans.
  • At the start of the research, published in the journal Nature, 40 monkeys were injected with either the experimental vaccine or the placebo vaccine, and then given a booster shot at six months.
  • The monkeys were then exposed to SIV six times through intra-rectal administration of the virus six months later.
  • After the virus was given the first time, about 75 per cent of monkeys in the placebo group became infected, whereas only 12 to 25 per cent of those given the vaccine developed infections. After the third exposure, about half the animals that received the experimental vaccine were infected and by the sixth time, almost all the animals were infected.
  • Still, those were on the experimental vaccine had a lower amount of virus in their blood than those given the placebo, the researchers found.
  • The results also showed that one vaccine ingredient — a protein called Env, which is involved with binding the virus with a cell — was key in helping to block the virus from entering the monkey’s cells, the researchers said.

Saturday, January 1, 2011

Revolutionary test for TB, Xpert MTB/RIF

  • A new test developed for diagnosing active tuberculosis is set to revolutionise treatment of a disease that kills 1.8 million people round the world every year.
  • It recently won approval from the World Health Organisation for a worldwide rollout over the next few years.
  • The new test has several advantages over the currently used smear microscopy and conventional nucleic acid-amplification method. While the sensitivity of smear microscopy is about 50 per cent, this (Xpert MTB/RIF) has 72 per cent sensitivity with one test, and 90 per cent with three tests in the case of smear-negative patients. The sensitivity goes up to 98 per cent in the case of smear-positive and culture-positive patients. Xpert has 99 per cent specificity. Further, the test's ability to provide reliable results within two hours, compared with 4-6 weeks in the case of culture, will help begin treatment earlier and reduce the chances of an individual infecting others. The greatest beneficiaries will be those co-infected with HIV and TB. The long wait for the results before starting TB treatment is one of the main reasons for the death of many co-infected individuals.
  • Unlike smear microscopy, Xpert can identify rifampicin drug resistance. It correctly identified 98 per cent of bacteria that were resistant to rifampicin. In India and many other countries where multidrug resistant TB (MDR-TB) is not high, much of the testing that goes on now is mainly for diagnosing active TB and not for drug resistance. But Xpert is all set to change this: rifampicin resistance is an excellent marker of MDR-TB. Most patients who are resistant to rifampicin are also resistant to isoniazid drug. Patients who are resistant to rifampicin will need culture to find out which drugs work for them. Following this protocol before starting the treatment will go a long way in preventing MDR-TB from becoming widespread. There is one major problem, however: the diagnostic test is prohibitively expensive. India being one of the high-burden countries, the public sector and certain NGOs will be eligible for a special pricing agreement. Uninterrupted power supply and temperature control, which are essential, will turn out to be major challenges in rural areas. India must find ways to embrace this technology swiftly after necessary field testing — considering that TB kills two Indians every three minutes.